|
"liu t w"的相關文件
顯示項目 111-135 / 158 (共7頁)
<< < 1 2 3 4 5 6 7 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2020-05-25T06:52:08Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'Ang H.-J;Wang C.-C;Cheng A.-L;Hsu C;Yen-Shen Lu;Chang M.-C;Lin J.-T;Wang H.-P;Shiah H.-S;Liu T.-W;Chang J.-Y;Whang-Peng J;Chen L.-T.; Ch'ang H.-J; Wang C.-C; Cheng A.-L; Hsu C; YEN-SHEN LU; Chang M.-C; Lin J.-T; Wang H.-P; Shiah H.-S; Liu T.-W; Chang J.-Y; Whang-Peng J; Chen L.-T. |
| 臺大學術典藏 |
2020-04-28T07:25:35Z |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah H.-S.;Cheng A.-L.;Hsu C.;Chih-Hung Hsu;Liu T.-W.;Chang J.-Y.;Jan C.-M.;Chao Y.;Yu W.-L.;Chuang T.-R.;Whang-Peng J.;Chen L.-T.; Shiah H.-S.; Cheng A.-L.; Hsu C.; CHIH-HUNG HSU; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2020-04-10T12:51:26Z |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Chen L.-T.; Shiah H.-S.;Cheng A.-L.;Chiun Hsu;Hsu C.-H.;Liu T.-W.;Chang J.-Y.;Jan C.-M.;Chao Y.;Yu W.-L.;Chuang T.-R.;Whang-Peng J.;Chen L.-T.; Shiah H.-S.; Cheng A.-L.; Chiun Hsu; Hsu C.-H.; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J. |
| 臺大學術典藏 |
2020-04-10T12:51:26Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'Ang H.-J.;Wang C.-C.;Cheng A.-L.;Chiun Hsu;Lu Y.-S.;Chang M.-C.;Lin J.-T.;Wang H.-P.;Shiah H.-S.;Liu T.-W.;Chang J.-Y.;Whang-Peng J.;Chen L.-T.; Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; Chiun Hsu; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2020-04-10T12:51:10Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Chiun Hsu; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; Chen P.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:05Z |
Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide
|
Chen L.-T.; Shih T.T.F.; Liu T.W.; Chiun Hsu; Liang P.-C.;Ch’Ang H.-J.;Chiun Hsu;Chen L.-T.;Shih T.T.F.;Liu T.W.; Liang P.-C.; Ch’ang H.-J. |
| 臺大學術典藏 |
2020-04-10T12:51:04Z |
A decade of changes in preferences for life-sustaining treatments among terminally ill patients with cancer
|
Chang C.-S.; Sung Y.-C.; Hsieh C.-I.; Chang S.-Y.; Liu L.N.; Chiang M.-C.; Tang S.T.;Liu T.-W.;Wen F.-H.;Chiun Hsu;Chang Y.-H.;Chang C.-S.;Sung Y.-C.;Hsieh C.-I.;Chang S.-Y.;Liu L.N.;Chiang M.-C.; Tang S.T.; Liu T.-W.; Wen F.-H.; Chiun Hsu; Chang Y.-H. |
| 臺大學術典藏 |
2020-04-10T12:51:00Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
Taiwan Cooperative Oncology Group; Chiun Hsu; Pei S.-N.; Chang C.-S.; Chen J.-H.; Yao M.; Lin S.-J.; Lin J.; Yuan Q.; Xia N.; Liu T.-W.; Chen P.-J.; Cheng A.-L.; Tsou H.-H.; Yang H.-C.; Yang H.-C.;Tsou H.-H.;Pei S.-N.;Chang C.-S.;Chen J.-H.;Yao M.;Lin S.-J.;Lin J.;Yuan Q.;Xia N.;Liu T.-W.;Chen P.-J.;Cheng A.-L.;Chiun Hsu;Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2020-04-10T12:50:59Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.;Yang H.-C.;Hsiao C.-F.;Hsiung C.A.;Liu T.-W.;Chuang M.-H.;Wu H.-Y.;Hsu Y.-T.;Tsui C.-W.;Chen P.-J.;Cheng A.-L.;Chiun Hsu;Taiwan Cooperative Oncology Group; Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; Chen P.-J.; Cheng A.-L.; Chiun Hsu; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2020-03-30T08:51:01Z |
Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status
|
Hsu C.-H.;Tseng C.-H.;Chiang C.-J.;Hsu K.-H.;Tseng J.-S.;Chen K.-C.;Wang C.-L.;Chen C.-Y.;Yen S.-H.;Chiu C.-H.;Huang M.-S.;Yu C.-J.;Tsai Y.-H.;Jin-Shing Chen;Tsai C.-M.;Chou T.-Y.;Lin K.-C.;Tsai M.-H.;Lee W.-C.;Ku H.-Y.;Liu T.-W.;Yang T.-Y.;Chang G.-C.; Chang G.-C.; Hsu C.-H.; Tseng C.-H.; Chiang C.-J.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; Wang C.-L.; Chen C.-Y.; Yen S.-H.; Chiu C.-H.; Huang M.-S.; Yu C.-J.; Tsai Y.-H.; JIN-SHING CHEN; Tsai C.-M.; Chou T.-Y.; Lin K.-C.; Tsai M.-H.; Lee W.-C.; Ku H.-Y.; Liu T.-W.; Yang T.-Y. |
| 臺大學術典藏 |
2020-03-30T08:50:56Z |
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
|
Wang C.-L.; Chen K.-C.; Hsu K.-H.; Yang T.-Y.; Tseng J.-S.; Tseng C.-H.; Chiang C.-J.; Tseng C.-H.;Chiang C.-J.;Tseng J.-S.;Yang T.-Y.;Hsu K.-H.;Chen K.-C.;Wang C.-L.;Chen C.-Y.;Yen S.H.;Tsai C.-M.;Huang M.-S.;Ho C.-C.;Yu C.-J.;Tsai Y.-H.;Jin-Shing Chen;Chou T.-Y.;Tsai M.-H.;Chen H.-Y.;Su K.-Y.;Chen J.J.W.;Chen H.-W.;Yu S.-L.;Liu T.-W.;Chang G.-C.; Chang G.-C.; Yu S.-L.; Liu T.-W.; Chen H.-W.; Chen J.J.W.; Su K.-Y.; Chen C.-Y.; Yen S.H.; Tsai C.-M.; Huang M.-S.; Ho C.-C.; Yu C.-J.; Tsai Y.-H.; JIN-SHING CHEN; Chou T.-Y.; Tsai M.-H.; Chen H.-Y. |
| 臺大學術典藏 |
2020-02-24T05:14:31Z |
Adult non-Hodgkin's lymphoma in Taiwan area: A clinicopathologic study of 123 cases based on working formulation classification
|
Cheng A.-L.; Chen Y.-C.; Su I.-J.; Wang C.-H.; Hsieh H.-C.; Chen C.-L.; HONG-SHIEE LAI; Liu T.-W.; Tien H.-F.; Shen M.-C.; Liu C.-H. |
| 臺大學術典藏 |
2020 |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai H.-J.; Tai J.J.; Chen L.-T.; MING-SHIANG WU; Yeh K.-H.; Lin C.-W.; Wang T.-E.; Wang H.-P.; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; Cheng T.-Y.; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; Shun C.-T.; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; Kuo S.-H.; Cheng A.-L. |
| 國立成功大學 |
2020 |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai, H.-J.;Tai, J.J.;Chen, L.-T.;Wu, M.-S.;Yeh, K.-H.;Lin, C.-W.;Wang, T.-E.;Wang, H.-P.;Yu, F.-J.;Liou, J.-M.;Hsiao, C.-F.;Cheng, T.-Y.;Yeh, H.-J.;Ko, C.-W.;Chen, M.-J.;Lo, G.-H.;Hsu, P.-I.;Chang, Chang C.-S.;Hwang, W.-S.;Chuang, S.-S.;Lee, H.-W.;Shun, C.-T.;Chiu, Chiu C.-F.;Wang, Wang W.-M.;Hsieh, C.-Y.;Liu, T.-W.;Lin, J.-T.;Kuo, S.-H.;Cheng, A.-L. |
| 國立成功大學 |
2020 |
An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas
|
Chen, M.-H.;Chou, W.-C.;Hsiao, C.-F.;Jiang, S.S.;Tsai, H.-J.;Liu, Y.-C.;Hsu, C.;Shan, Y.-S.;Hung, Y.-P.;Hsich, C.-H.;Chiu, Chiu C.-H.;Liu, T.-C.;Cho, S.-F.;Liu, T.-W.;Chao, Y. |
| 臺大學術典藏 |
2018-09-10T09:13:56Z |
Development and Validation of an Instrument for the Measurement of Health-Related Quality of Life Based on View of Traditional Chinese Medicine Perspective
|
Chang, H.-H.;Chie, W.-C.;Chin, Y.-H.;Hsu, C.-P.;Liu, T.-W.;Whang-Peng, J.; WEI-CHU CHIE |
| 臺大學術典藏 |
2018 |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Liu T.W.; Lai S.C; Tsai M.H; Wang H.M; PEI-JEN LOU; Chang J.T.C; Wang C.W; Ko J.Y; Hong R.L; Hsiao C.F; Ting L.L |
| 國立成功大學 |
2018 |
Adjuvant radiotherapy after curative surgery for oral cavity squamous cell carcinoma and treatment effect of timing and duration on outcome—A Taiwan Cancer Registry national database analysis
|
Cheng, Y.-J.;Tsai, M.-H.;Chiang, Chiang C.-J.;Tsai, S.-T.;Liu, T.-W.;Lou, P.-J.;Liao, C.-T.;Lin, J.-C.;Chang, J.T.-C.;Tsai, M.-H.;Chu, P.-Y.;Leu, Y.-S.;Tsai, K.-Y.;Terng, S.-D.;Chien, Chien C.-Y.;Yang, M.-H.;Hao, S.-P.;Wang, C.-C.;Tsai, M.-H.;Chen, H.H.W.;Kuo, C.;Wu, Y.-H. |
| 國立成功大學 |
2018 |
The clinical impact of the novel tumor marker DR-70 in unresectable gastric cancer patients
|
Hung, Y.-P.;Chen, M.-H.;Lin, J.-S.;Hsiao, C.-F.;Shan, Y.-S.;Chen, Y.-C.;Chen, L.-T.;Liu, T.-W.;Li, C.-P.;Chao, Y. |
| 國立臺灣科技大學 |
2017 |
Energy-aware run-time task partition and allocation in dynamic partial reconfigurable systems
|
Liu, T.-W.;Liu, Y.-F.;Chen, Y.-S. |
| 臺大學術典藏 |
2017 |
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
|
Chou T.-Y.; Tsai M.-H.; Chen J.-S.; Tsai Y.-H.; Yu C.-J.; CHAO-CHI HO; Huang M.-S.; Tsai C.-M.; Yen S.H.; Tseng C.-H.; Chiang C.-J.; Tseng J.-S.; Yang T.-Y.; Hsu K.-H.; Chen K.-C.; Wang C.-L.; Chen C.-Y.; Chang G.-C.; Liu T.-W.; Chen H.-Y.; Su K.-Y.; Chen J.J.W.; Chen H.-W.; Yu S.-L.; Tseng C.-H.;Chiang C.-J.;Tseng J.-S.;Yang T.-Y.;Hsu K.-H.;Chen K.-C.;Wang C.-L.;Chen C.-Y.;Yen S.H.;Tsai C.-M.;Huang M.-S.;Chao-Chi Ho;Yu C.-J.;Tsai Y.-H.;Chen J.-S.;Chou T.-Y.;Tsai M.-H.;Chen H.-Y.;Su K.-Y.;Chen J.J.W.;Chen H.-W.;Yu S.-L.;Liu T.-W.;Chang G.-C. |
| 臺大學術典藏 |
2017 |
Clinical Outcomes of Taiwanese Patients with cT4 Oral Cavity Squamous Cell Carcinoma: Toward the Identification of the Optimal Initial Treatment Approach for cT4b Patients
|
Wang H.-M; Lin C.-Y; Lee L.-Y; Chen W.-C; Chien C.-Y; Wang C.-H; Liao C.-T; Wen Y.-W; Lee S.R; Liu T.-W; Tsai S.-T; Tsai M.-H; Lin J.-C; PEI-JEN LOU; Chu P.-Y; Leu Y.-S; Tsai K.-Y; Terng S.-D; Chen T.-M; Ng S.-H; Lin C.-H; Fang T.-J; Huang S.-F; Kang C.-J; Chang K.-P; Yang L.Y; Yen T.-C; for the Taiwan Oral Cancer Advisory Group |
| 國立成功大學 |
2017 |
Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas
|
Liao, C.-T.;Wen, Y.-W.;Yang, L.Y.;Lee, S.R.;Ng, S.-H.;Liu, T.-W.;Tsai, S.-T.;Tsai, M.-H.;Lin, J.-C.;Chen, P.-R.;Lou, P.-J.;Wang, C.P.;Chu, P.-Y.;Hwang, T.-Z.;Leu, Y.-S.;Tsai, K.-Y.;Terng, S.-D.;Chen, T.-M.;Wang, C.-H.;Chien, Chien C.-Y.;Chen, W.-C.;Lee, Lee L.-Y.;Lin, C.-Y.;Wang, H.-M.;Hsieh, C.-H.;Tsao, C.-K.;Fang, T.-J.;Huang, S.-F.;Kang, C.-J.;Chang, K.-P.;Yen, T.-C. |
| 國立成功大學 |
2017 |
Clinical Outcomes of Taiwanese Patients with cT4 Oral Cavity Squamous Cell Carcinoma: Toward the Identification of the Optimal Initial Treatment Approach for cT4b Patients
|
Liao, C.-T.;Wen, Y.-W.;Lee, S.R.;Liu, T.-W.;Tsai, S.-T.;Tsai, M.-H.;Lin, J.-C.;Lou, P.-J.;Chu, P.-Y.;Leu, Y.-S.;Tsai, K.-Y.;Terng, S.-D.;Chen, T.-M.;Wang, C.-H.;Chien, Chien C.-Y.;Chen, W.-C.;Lee, Lee L.-Y.;Lin, C.-Y.;Wang, H.-M.;Ng, S.-H.;Lin, C.-H.;Fang, T.-J.;Huang, S.-F.;Kang, C.-J.;Chang, K.-P.;Yang, L.Y.;Yen, T.-C.;Group, for the Taiwan Oral Cancer Advisory |
| 國立成功大學 |
2017 |
Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma
|
Liao, C.-T.;Chen, H.-N.;Wen, Y.-W.;Lee, S.R.;Ng, S.-H.;Liu, T.-W.;Tsai, S.-T.;Tsai, M.-H.;Lin, J.-C.;Lou, P.-J.;Wang, C.P.;Chu, P.-Y.;Leu, Y.-S.;Tsai, K.-Y.;Terng, S.-D.;Chen, T.-M.;Wang, C.-H.;Chien, Chien C.-Y.;Chen, W.-C.;Lee, Lee L.-Y.;Lin, C.-Y.;Wang, H.-M.;Lin, C.-H.;Fang, T.-J.;Huang, S.-F.;Kang, C.-J.;Chang, K.-P.;Yang, L.Y.;Yen, T.-C. |
顯示項目 111-135 / 158 (共7頁)
<< < 1 2 3 4 5 6 7 > >>
每頁顯示[10|25|50]項目
|
